Target Price | $40.80 |
Price | $32.85 |
Potential | 24.20% |
Number of Estimates | 19 |
19 Analysts have issued a price target Keurig Dr Pepper Inc 2026 . The average Keurig Dr Pepper Inc target price is $40.80. This is 24.20% higher than the current stock price. The highest price target is $46.20 40.64% , the lowest is $34.34 4.54% . | |
A rating was issued by 25 analysts: 17 Analysts recommend Keurig Dr Pepper Inc to buy, 8 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Keurig Dr Pepper Inc stock has an average upside potential 2026 of 24.20% . Most analysts recommend the Keurig Dr Pepper Inc stock at Purchase. |
21 Analysts have issued a sales forecast Keurig Dr Pepper Inc 2025 . The average Keurig Dr Pepper Inc sales estimate is $16.3b . This is 5.29% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $17.2b 10.91% , the lowest is $15.7b 0.95% .
This results in the following potential growth metrics:
2024 | $15.4b | 3.62% |
---|---|---|
2025 | $16.3b | 6.44% |
2026 | $17.0b | 3.98% |
2027 | $17.6b | 3.64% |
2028 | $18.2b | 3.11% |
2029 | $18.9b | 3.87% |
2030 | $19.5b | 3.62% |
2031 | $20.3b | 4.09% |
2032 | $21.1b | 3.98% |
17 Analysts have issued an Keurig Dr Pepper Inc EBITDA forecast 2025. The average Keurig Dr Pepper Inc EBITDA estimate is $4.9b . This is 36.22% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $5.2b 46.29% , the lowest is $4.3b 21.47% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $3.7b | 6.25% |
---|---|---|
2025 | $4.9b | 30.58% |
2026 | $5.1b | 5.17% |
2027 | $5.4b | 4.77% |
2028 | $5.2b | 3.25% |
2029 | $5.4b | 3.67% |
2030 | $5.6b | 3.78% |
2031 | $5.4b | 2.64% |
2032 | $5.6b | 3.69% |
2024 | 24.24% | 2.54% |
---|---|---|
2025 | 29.74% | 22.69% |
2026 | 30.08% | 1.14% |
2027 | 30.41% | 1.10% |
2028 | 28.53% | 6.18% |
2029 | 28.48% | 0.18% |
2030 | 28.52% | 0.14% |
2031 | 26.68% | 6.45% |
2032 | 26.60% | 0.30% |
23 Keurig Dr Pepper Inc Analysts have issued a net profit forecast 2025. The average Keurig Dr Pepper Inc net profit estimate is $2.8b . This is 85.86% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $2.9b 95.33% , the lowest is $2.7b 76.99% .
This results in the following potential growth metrics and future Net Margins:
2024 | $1.4b | 33.93% |
---|---|---|
2025 | $2.8b | 93.99% |
2026 | $3.0b | 6.41% |
2027 | $3.2b | 6.61% |
2028 | $3.1b | 1.85% |
2029 | $3.0b | 2.60% |
2030 | $3.3b | 8.14% |
2031 | $3.6b | 8.37% |
2032 | $3.8b | 7.72% |
2024 | 9.39% | 36.24% |
---|---|---|
2025 | 17.11% | 82.27% |
2026 | 17.51% | 2.34% |
2027 | 18.01% | 2.86% |
2028 | 17.14% | 4.83% |
2029 | 16.08% | 6.18% |
2030 | 16.78% | 4.35% |
2031 | 17.47% | 4.11% |
2032 | 18.10% | 3.61% |
23 Analysts have issued a Keurig Dr Pepper Inc forecast for earnings per share. The average Keurig Dr Pepper Inc EPS is $2.06 . This is 87.27% higher than earnings per share in the financial year 2024. The highest EPS forecast is $2.16 96.36% , the lowest is $1.96 78.18% .
This results in the following potential growth metrics and future valuations:
2024 | $1.05 | 32.26% |
---|---|---|
2025 | $2.06 | 96.19% |
2026 | $2.19 | 6.31% |
2027 | $2.33 | 6.39% |
2028 | $2.29 | 1.72% |
2029 | $2.23 | 2.62% |
2030 | $2.41 | 8.07% |
2031 | $2.62 | 8.71% |
2032 | $2.82 | 7.63% |
Current | 29.86 | 34.64% |
---|---|---|
2025 | 15.96 | 46.56% |
2026 | 15.00 | 6.02% |
2027 | 14.07 | 6.20% |
2028 | 14.34 | 1.92% |
2029 | 14.72 | 2.65% |
2030 | 13.61 | 7.54% |
2031 | 12.56 | 7.71% |
2032 | 11.66 | 7.17% |
Based on analysts' sales estimates for 2025, the Keurig Dr Pepper Inc stock is valued at an EV/Sales of 3.72 and an P/S ratio of 2.73 .
This results in the following potential growth metrics and future valuations:
Current | 3.91 | 5.78% |
---|---|---|
2025 | 3.72 | 4.92% |
2026 | 3.58 | 3.83% |
2027 | 3.45 | 3.51% |
2028 | 3.35 | 3.01% |
2029 | 3.22 | 3.73% |
2030 | 3.11 | 3.49% |
2031 | 2.99 | 3.93% |
2032 | 2.87 | 3.83% |
Current | 2.88 | 7.90% |
---|---|---|
2025 | 2.73 | 5.03% |
2026 | 2.63 | 3.83% |
2027 | 2.53 | 3.51% |
2028 | 2.46 | 3.01% |
2029 | 2.37 | 3.73% |
2030 | 2.28 | 3.49% |
2031 | 2.19 | 3.93% |
2032 | 2.11 | 3.83% |
Keurig Dr Pepper Inc...
Analyst | Rating | Action | Date |
---|---|---|---|
Barclays |
Overweight
➜
Overweight
|
Unchanged | Jun 27 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Apr 28 2025 |
HSBC |
Hold
➜
Buy
|
Upgrade | Apr 25 2025 |
RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Apr 22 2025 |
UBS |
Buy
➜
Buy
|
Unchanged | Apr 17 2025 |
Argus Research |
➜
Buy
|
Initiated | Apr 16 2025 |
Piper Sandler |
Neutral
➜
Overweight
|
Upgrade | Apr 09 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Jun 27 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Apr 28 2025 |
Upgrade
HSBC:
Hold
➜
Buy
|
Apr 25 2025 |
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Apr 22 2025 |
Unchanged
UBS:
Buy
➜
Buy
|
Apr 17 2025 |
Initiated
Argus Research:
➜
Buy
|
Apr 16 2025 |
Upgrade
Piper Sandler:
Neutral
➜
Overweight
|
Apr 09 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.